Generic Name and Formulations:
Riluzole 50mg; tabs.
Covis Pharmaceuticals, Inc.
Indications for RILUTEK:
Amyotrophic lateral sclerosis (ALS).
Take on an empty stomach. 50mg every 12 hours.
Hepatic insufficiency; discontinue if ALT ≥5xULN or if jaundice develops; rechallenge not recommended. Measure LFTs before and during therapy: ALT every month for first 3 months, every 3 months for the remainder of the year, then periodically thereafter. Increased risk of neutropenia; monitor for febrile illness and obtain WBC. Perform chest radiography if respiratory symptoms develop. Females. Elderly. Pregnancy (Cat.C). Nursing mothers: not recommended.
Caution with concomitant hepatotoxic agents (eg, allopurinol, methyldopa, sulfasalazine). Avoid excessive alcohol. May be potentiated by CYP1A2 inhibitors (eg, caffeine, phenacetin, theophylline, amitriptyline, quinolones). May be antagonized by CYP1A2 inducers (eg, cigarette smoke, charcoal-broiled food, rifampicin, omeprazole).
Asthenia, nausea, dizziness, decreased lung function, diarrhea, abdominal pain, pneumonia, vomiting, vertigo, circumoral paresthesia, anorexia, somnolence; abnormal liver function tests, neutropenia, interstitial lung disease, hypersensitivity pneumonitis.
Endocrinology Advisor Articles
- Long-Term Efficacy and Safety of Dapagliflozin for Type 1 Diabetes
- Measuring Time in Range During CGM May Be Useful Outcome Metric for Clinical Trials
- HbA1c Variability in General Population Increases Risk for Cardiovascular Events, All-Cause Mortality
- Safety and Effectiveness of the Most Common Bariatric Procedures Examined
- AHA, ADA Announce Joint Education Initiative to Reduce CVD Deaths in T2D
- High Circulating Prolactin Concentrations May Lower Risk for Type 2 Diabetes
- Online Tool Helps Patients With Advance Care Planning
- Dapagliflozin Lowers Heart Failure Hospitalization Rates in High-Risk Patients With Diabetes
- Direct-Acting Antiviral Therapy Reduced Risk for Incident T2D in Patients With Hepatitis C Infection
- Technological Breakthroughs in Medicine Move Physician-Patient Interactions From The Computer Screen Back to the Exam Room